The prognostic significance of pathological Q waves appearing in the acute phase of myocardial infarction has not been determined. We investigated whether new Q waves on the presenting electrocardiogram of patients with acute ST-segment elevation were independently associated with a worse outcome after a first myocardial infarction.
Introduction
In patients presenting with ST-elevation myocardial infarction, the presence of pathological Q waves on the electrocardiogram is usually considered to signify irreversible myocardial necrosis. Early restoration of complete infarct artery perfusion after coronary occlusion is the most important goal in the management of infarction [1] . The prognostic significance of pathological Q waves appearing very early in the course of acute myocardial infarction has not yet been determined.
In this study, we investigated the relationship between the appearance of new pathological Q waves on the presenting electrocardiogram and the outcome of patients with a first acute ST-elevation myocardial infarction who presented within 4 h of symptom onset and were treated with intravenous streptokinase.
Methods

Study population
Patients randomized from 1989 to 1994 in a trial of placebo or oral captopril 2 h after thrombolytic therapy with streptokinase formed the study group [2] . The patients were aged c75 years, had not previously had a myocardial infarction, had no prior Q waves, and had presented within 4 h of the onset of d30 min of ischaemic chest pain with d1 mm of ST-segment elevation in two contiguous leads or d2 mm in leads V 1 -V 3 . Patients received oral aspirin, intravenous streptokinase and heparin, and beta-blockers as described previously [2] . Medications such as calcium-channel blockers and nitrates were prescribed only for post-infarction angina.
All patients were advised to stop smoking, lose weight, exercise regularly and consume a low-saturated-fat diet.
Coronary and left ventricular angiography were performed 3 weeks after infarction unless medically uncontrolled ischaemia mandated earlier investigation. Angiographic flow assessments were made using the Thrombolysis in Myocardial Infarction (TIMI) flow grading criteria [3] . Left ventriculography was performed in the 40 right anterior oblique projection.
Electrocardiographic analysis
The electrocardiogram recorded just prior to commencement of the streptokinase infusion was regarded as the 'presenting electrocardiogram'. Q waves on the presenting electrocardiogram were presumed to be new unless the patient was known to have had electrocardiography on a previous occasion, and had Q waves on the most recent previous electrocardiogram available for review. Pathological Q waves were defined using the criteria developed by Selvester et al. as follows: for leads I, II, III, aVL, aVF, V 5 and V 6 a Q wave of d30 ms, for lead V 4 a Q wave of d20 ms, and for leads V 1 -V 3 any Q wave [4] . For the purpose of the study, ST elevation in leads V 1 -V 6 , I or aVL was classified as anterior myocardial infarction, while ST elevation in leads II, III and aVF was classified as inferior infarction. For anterior infarction, only leads V 1 -V 6 , I and aVL were assessed for the presence or absence of new Q waves. Similarly, for inferior infarction, only leads II, III and aVF were assessed. If new Q waves were present in both the anterior and inferior territory, the patient was included for analysis in both the inferior and anterior infarction subgroups.
Follow-up
Follow-up was performed either by recall to the clinic or by telephone or mail contact with the patient, a relative, or the family doctor. End-points, including revascularization, were verified by source documentation, and deaths were classified as cardiac (sudden cardiac death, death occurring within 30 days of recurrence of prolonged chest pain with or without confirmation of re-infarction, death resulting from progressive cardiac failure, death after cardiac surgery) or non-cardiac [5] .
Statistical analysis
Two sample t, Mann-Whitney non-parametric and chisquare tests were performed to identify any differences in baseline patient characteristics or outcomes between patients with and those without new Q waves on their presenting electrocardiogram. Multivariate logistic regression was performed to identify baseline characteristics independently associated with the presence of new Q waves on the presenting electrocardiogram. Cox proportional hazards regression was used to identify multivariate predictors of cardiac and total mortality during follow-up. Survival curves were constructed using the Kaplan-Meier method and compared using the log-rank test.
Results
Of the 512 patients enrolled in the trial, 481 had presenting electrocardiograms on which the presence or absence of Q waves was able to be determined. The presenting electrocardiograms of the remaining 31 patients were either not available or were technically unsuitable for analysis. The 481 patients included in the present study were followed-up at a mean of 5·6 years [interquartile range (IQR) 4·3-6·3 years]. Four hundred and thirty-seven patients (91%) had coronary angiography and left ventriculography performed at 22 6 days after enrolment. Two hundred and thirty-eight patients had ST elevation in the inferior territory and 243 had ST elevation in the anterior territory; 52 patients had both inferior and anterior ST elevation. One hundred and sixty patients had new Q waves on their presenting electrocardiogram, and of these, 31 patients had inferior ST elevation and 137 had anterior ST elevation (i.e. eight patients had both inferior and anterior ST elevation).
Influence of baseline characteristics on new Q wave formation
The baseline patient characteristics are shown in Tables  1 and 2 . There were no differences between patients with and those without new Q waves at presentation, except that in the subgroup with anterior infarction, patients with new Q waves on the presenting electrocardiogram were older than those without new Q waves (59·4 years vs 56·9 years, P=0·03) ( Table 2) . None of the baseline characteristics independently influenced new Q wave formation ( Table 3 ). The presence or absence of new Q waves on the presenting electrocardiogram was not related to the time between symptom onset and commencement of streptokinase (odds ratio 1·07, 95% confidence interval 0·93-1·24, P=0·33).
New Q waves at presentation and ventricular function Ejection fraction
Overall, and in the subgroup with anterior infarction, patients with new Q waves on the presenting electrocardiogram had lower ejection fractions than those without new Q waves (51 13% vs 61 12%, P<0·0001; and 49 13% vs 61 13%; P<0·0001, respectively).
There was no significant difference in the subgroup with inferior infarction (57 11% vs 60 11%, P=0·16). 
Left ventricular volumes
New Q waves and mortality
The presence of new Q waves at presentation was associated with higher cardiac mortality rates in the total patient group (7% vs 2% at 30 days, P=0.01; 9% vs 3% at 1 year, P=0·01; 16% vs 6% at 5 years, P<0·001; and 17% vs 7% at overall follow-up, P=0·001, odds ratio 2·51, 95% confidence interval 1·40-4·52) (Fig. 1) and in the subgroup with anterior infarction (8% vs 3% at 30 days, P=0·03; 8% vs 3% at 1 year, P=0·03; 16% vs 5% at 5 years, P=0·002; and 18% vs 7% at overall follow-up, P=0·004, odds ratio 2·84, 95% confidence interval 1·40-4·52) (Fig. 2) .
In the subgroup with inferior infarction, 3% of patients with new Q waves at presentation and 2% of those without new Q waves died within 30 days (P=0·8). Over the period of follow-up there was a non-significant trend towards increased cardiac mortality in patients with new Q waves (6% vs 2% at 1 year, P=0·07; 16% vs 7% at 5 years, P=0·09; and 16% vs 8% at overall follow-up, P=0·15, odds ratio 2·15, 95% confidence interval 0·73-6·32) (Fig. 3) .
Similarly, patients with new Q waves at presentation had an increased incidence of death from any cause (total mortality) at overall follow-up compared with patients without new Q waves (22% vs 14%; P=0·02). In the subgroup of patients with anterior infarction, new Q waves at presentation were associated with a total mortality of 23% vs 13% in those without new Q waves (P=0·02), while in patients with inferior infarction, the total mortality was 19% in patients with new Q waves and 14% in those without new Q waves (P=0·48).
Among patients with and those without new Q waves at presentation, the median cholesterol level at follow-up was 5·6 mmol . l 1 in each group (P=0·42). Thirteen percent of patients in each group continued to smoke (P=0·9), with 25% quitting during the course of the study. ACE inhibitors were prescribed more frequently in patients with new Q waves at presentation (47% vs 26%, P<0·001), while beta-blockers (31% vs 41%, P=0·005) and lipid-modifying therapy (22% vs 32%, P=0·016) were prescribed less frequently. The rates of revascularization during follow-up were 18% in patients with new Q waves at presentation and 24% in those without new Q waves (P=0·12). 
Infarct-related artery flow
There were no differences in TIMI flow grades at 3 weeks between patients with and those without new Q waves on the presenting electrocardiogram. Of the patients with TIMI 0-1 flow, 28 (25%) had new Q waves while 50 (75%) did not; 21 patients (42%) with TIMI 2 flow had new Q waves while 29 (58%) did not; and 93 patients (34%) with TIMI 3 flow had new Q waves while 183 (66%) did not (P=0·17). There were also no differences in TIMI flow grades between patients with and those without new Q waves in the subgroups of anterior or inferior infarction (P=0·96 and P=0·20, respectively).
Independent predictors of cardiac mortality
Three multivariate predictors of cardiac death were identified: age in years as a continuous variable (risk ratio 1·06, 95% confidence interval 1·02-1·10; P<0·01), new Q waves on the baseline electrocardiogram (risk 
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ratio 2·22, 95% confidence interval 1·25-3·92; P<0·01) and a history of previous angina (risk ratio 1·77, 95% confidence interval 1·00-3·16; P=0·046). Following this, a similar model was constructed to assess the relationship between the baseline patient characteristics and total mortality. In this model, age in years as a continuous variable (P<0·001), diabetes mellitus (P=0·028) and new Q waves at presentation (P=0·048) were independent predictors of total mortality.
Discussion
Our study demonstrates that pathological Q waves appearing very early in the course of a first acute ST-elevation myocardial infarction (c4 h after symptom onset) are associated with larger infarcts and increased cardiac and total mortality. On multivariate analysis, their appearance predicted an increased incidence of cardiac (and total) mortality, independent of the time from symptom onset to thrombolytic therapy. These associations remained significant in patients with anterior infarction. As only 31 patients with inferior infarction had new Q waves at presentation, this subgroup did not have sufficient power to detect a significant difference. Pathological Q waves developing within 6 h of symptom onset have been shown to be associated with a larger infarct size, as measured by quantitative thallium-201 tomography, at a mean of 52 days after infarction [6] , and a higher incidence of in-hospital mortality [7] . In the first study, the development of early Q waves was significantly associated with a longer time from symptom onset to thrombolytic therapy. Furthermore, abnormal Q waves were associated with a larger infarct size only when the duration of symptoms was taken into account [6] . In the second paper, new Q waves on the presenting electrocardiogram were also significantly more likely to occur in patients with a longer time from symptom onset to thrombolytic therapy (P=0·01) [7] . The absence of pathological Q waves on a presenting electrocardiogram taken within 12 h of symptom onset has been reported as predicting the probability of achieving successful complete infarct artery reperfusion (TIMI 3 flow) at 90 min after thrombolytic therapy [8] . In this particular study, both the time from symptom onset to thrombolytic therapy and the absence of pathological Q waves on the presenting electrocardiogram were independently associated with infarct artery flow at 90 min [8] . Other authors have hypothesized that Q waves appearing during the early stages of myocardial infarction may not always signify irreversible myocardial necrosis, but may be due to another mechanism. Intra-myocardial conduction abnormalities secondary to ischaemia may cause transient Q wave formation [9] , particularly in the anterior leads [10] . In the current study, new Q waves on the presenting electrocardiogram were associated with a higher degree of ventricular dysfunction at 3 weeks, and increased late cardiac and total mortality. This would suggest that the development of Q waves was most likely secondary to myocardial necrosis and not a more benign mechanism. The presence of new Q waves on the presenting electrocardiogram may be a more accurate predictor of ischaemic time than an estimated time of symptom onset reported by a distressed patient on admission to hospital. Elderly patients may have an inaccurate recall of events, and their perception of pain may also be impaired. In our study, patients with new Q waves and anterior infarction were older than those without, possibly suggesting a longer time from the onset of myocardial ischaemia to presentation than was recalled by the patient. Also, in patients with several episodes of pain it may be difficult to pinpoint the exact time of the onset of infarction. Finally, cardiac ischaemia may be 'silent', which is classically described in patients with diabetes mellitus, but can also occur in patients without this condition [11, 12] . In these settings, the presence of new pathological Q waves may be a better indicator of the duration of the ischaemic insult.
Recording the presence or absence of new Q waves at admission is a useful way of assessing myocardial ischaemic time, and may be of greater use than the patient's perception of the time of symptom onset. Patients with new Q waves could be identified at a very early stage as being at higher risk of developing larger infarctions and the associated complications, and appropriate risk stratification could take place. Although patients who have pathological Q waves in the early phase of infarction go on to develop larger final infarct sizes, important [15] . myocardial salvage is still possible with thrombolytic therapy, and so this should still be administered [6, 13] .
Study limitations
Why some patients develop early pathological Q waves while others do not may, in part, be due to the presence or absence of effective collateral circulation early after coronary occlusion. Therefore, it is a limitation of this study that acute coronary angiography was not performed, and the influence of a collateral circulation on Q wave formation could not be assessed. The effect of collateral coronary flow on early Q wave formation requires prospective investigation. Although significant measures were taken to ensure that new Q waves were indeed 'new', it is possible that a few of the patients may have had pre-existing Q waves in the area of the myocardium reflecting new ST segment elevation [14] . Also, only 91% of patients had coronary angiography and left ventriculography performed at 3 weeks, which may have introduced bias as the patients with worst outcomes may have died, or may have not undergone cardiac catheterization due to co-morbidity. In addition, there were differences in secondary prevention therapies during follow-up. Patients with new Q waves on the presenting electrocardiogram were more frequently prescribed ACE inhibitors than those without new Q waves, but less frequently prescribed beta-blockers or lipid-modifying therapy. These differences may have influenced late survival.
Conclusion
New pathological Q waves on the presenting electrocardiogram are associated with higher incidences of ventricular dysfunction and cardiac death following a first myocardial infarction. Identification of new Q waves on the presenting electrocardiogram may allow very early risk stratification of patients at high risk of developing larger infarctions and consequently a worse outcome after acute myocardial infarction.
